Dr Kola Tytler MBBS CertHE MBA MRCGPClinical Lead • iatroX
For a patient presenting with recurrent miscarriages (defined as three or more first-trimester miscarriages), referral for investigation and management is recommended NICE CKS. As part of this investigation, pre-conception screening for antiphospholipid antibodies, specifically lupus anticoagulant and anticardiolipin antibodies, should be offered NICE CKS,NICE CKS.
Interpretation of results:
- If antiphospholipid antibodies are found, this indicates that treatment with aspirin plus heparin will be considered in future pregnancies, continuing until at least 34 weeks of gestation NICE CKS.
- The interpretation of thrombophilia screen results, including antiphospholipid antibodies, should be undertaken by clinicians with expertise in this area NICE CKS.
- Women who have experienced recurrent miscarriage should be managed by a person with the necessary skills and expertise, and offered referral to a specialist clinic NICE CKS.
Further considerations:
- Antiphospholipid syndrome is also identified as an autoimmune disease that places pregnant women at high risk of pre-eclampsia, for which daily aspirin (75 mg to 150 mg) from 12 weeks until birth is advised NICE NG133.
Key References
- CKS - Miscarriage
- CKS - Pre-conception - advice and management
- NG137 - Twin and triplet pregnancy
- NG133 - Hypertension in pregnancy: diagnosis and management
- CKS - Deep vein thrombosis
- NG89 - Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism